LOTUS PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 287 TWD | +2.14% |
|
+1.77% | +5.51% |
ETFs positioned on Lotus Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.01% | 112 M€ | +5.51% | - | |
| 0.00% | 34 M€ | +4.26% | - | |
| 0.00% | 7 M€ | +0.11% | - |
Lotus Pharmaceutical Co Ltd is a Taiwan-based company mainly engaged in the manufacture and sale of generic drugs. The products are mainly solid preparations such as tablets and capsules. The main products include oral anti-cancer drugs, cardiovascular disease drugs, central nervous system drugs, women's health products, osteoporosis drugs and mental disease drugs. The Company is also engaged in the drug research, development and clinical testing business, as well as the product licensing business. The Company mainly distributes products in Taiwan, South Korea, the United States, China mainland, Japan, Europe and Southeast Asia markets.
Sector
Pharmaceuticals
Calendar
13/06/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
287
TWD
Average target price
390.2
TWD
Spread / Average Target
+35.96%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.51% | 236.01Cr | |
| +32.36% | 69TCr | |
| +31.01% | 59TCr | |
| -1.60% | 37TCr | |
| +20.07% | 33TCr | |
| +6.04% | 29TCr | |
| +14.66% | 24TCr | |
| +10.19% | 21TCr | |
| -3.03% | 21TCr | |
| +9.27% | 17TCr |
- Stock Market
- Equities
- 1795 Stock
- Funds and ETFs Lotus Pharmaceutical Co., Ltd.
